Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.37
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company is headquartered in Carson City, Nevada.
See the full interactive analysis & chart →Informational only — not investment advice.